Primary record
Dacomitinib
- CAS
- 1110813-31-4
- PubChem CID
- 11511120
- SMILES
- COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4
- Molecular Formula
- C24H25ClFN5O2
- Molecular Weight
- 469.948
- Exact Mass
- 469.1681
- InChI
- InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
- InChIKey
- LVXJQMNHJWSHET-AATRIKPKSA-N
- LogP
- 5.1551
- TPSA
- 79.38
Names and synonyms
- Dacomitinib
- 1110813-31-4
- Vizimpro
- dacomitinibum
- Dacomitinib anhydrous
- Dacomitinib [USAN]
- Dacomitinib monohydrate
- Dacomitinib (INN)
- Dacomitinib (PF299804)
- DACOMITINIB HYDRATE
- PF-00299804
- Dacomitinib (PF299804, PF299)
- Dacomitinib (Standard)
- Dacomitinib [USAN:INN]
- PF299804
- RefChem:585148
- C24H25ClFN5O2
- DACOMITINIB [INN]
- D06XXH
- UNII-2XJX250C20
- Dacomitinib, PF299804
- 2XJX250C20
- MFCD19443734
- SCHEMBL33147
- DACOMITINIB [WHO-DD]
- cc-194
- MLS006011275
- CHEBI:132268
- DTXSID50149493
- PF-299